Our finding that CT-proET-1 correlates with NT-proBNP and IL-8 suggests that measuring these three biomarkers in combination may be a powerful predictor of outcome in chronic heart failure, or a better index for assessing the effectiveness of new treatments. The gene discussed is NPPB; the disease is congestive heart failure.